ASP015K
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics of ASP015K
Conditions
Pharmacokinetics of ASP015K, Bioavailability of ASP015K, Healthy Subjects
Trial Timeline
Sep 1, 2011 → Oct 1, 2011
NCT ID
NCT01484964About ASP015K
ASP015K is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of ASP015K. The current trial status is completed. This product is registered under clinical trial identifier NCT01484964. Target conditions include Pharmacokinetics of ASP015K, Bioavailability of ASP015K, Healthy Subjects.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics of ASP015K were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02586194 | Phase 1 | Completed |
| NCT02603497 | Phase 1 | Completed |
| NCT01929577 | Phase 1 | Completed |
| NCT01484964 | Phase 1 | Completed |
| NCT01486017 | Phase 1 | Completed |
| NCT01406132 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics of ASP015K